We also performed high-throughput autoantigen array analysis in serum samples to assess the spectrum of antigens recognized by SLE patients with the DAP1 risk allele using an autoantigen array containing 90 autoantigens previously implicated in a variety of autoimmune diseases including SLE [64]. This evidence concerns the gene DAP and autoimmune disease.